N4 Pharma's latest press release regarding Nuvec®, an engineered silica nanoparticle, which has been designed for the intracellular delivery of large nucleic acids such as pDNA and mRNA and is in the advanced research phase.
SMi is delighted to present its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference, taking place in London on the 13th-14th May 2019.
In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up with Douglas Cusato from Sumitomo Rubber to discuss his presentation, current challenges and the upcoming event.
Industry experts from Amgen and GSK will be presenting on regulatory updates and patient safety on day one of the 2nd annual Injectable Drug Delivery conference in London.
Hear from Sanofi as they will be presenting the Keynote Address: Overcoming the challenges in development of injectable protein formulations on day one by Vasco Filipe, Senior research scientist - Formulation Development at the 2nd annual Injectable Drug Delivery conference taking place on the 15-16 May 2019, in London, UK.
SMi Reports: Superbugs & Superdrugs conference co-chairs have released a letter of invitation for the 21st annual event, taking place on 18th-19th March 2019 in London.
SMi Group’s next 11th annual conference is thrilled to welcome Heiko Goette, Biostatistician from Merck speaking about simulated development programs that are shaping state of the art adaptive design techniques.
SMi reports: Senior industry experts are set to speak and present at the 10th Annual RNA Therapeutics Conference, taking place on 20th – 21st February 2019 in London in less than 4 weeks.
SMi reports: Associate Director at ProQR is set to present at the 10th Annual RNA Therapeutics Conference, taking place on 20th – 21st February 2019 in London.
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. This collaboration, between Bioquark Inc. and Ectocrine Technologies LLC, is the first of its kind to explore the possibilities for the benefit of humanity.
SMi reports: Industry peers and experts to join together at SMi’s 6th Annual Pre-Filled Syringes East Coast Conference and exhibition this April 8th - 9th in Boston, MA.
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
SMi Group’s next annual Adaptive Designs in Clinical Trials conference is thrilled to welcome Sandeep Menon, Vice President and Head of Early Clinical Development at Pfizer Inc. onto the speaker panel for 2019.
SMi Reports: Chief Scientific Officer of MiNA Therapeutics set to speak at RNA Therapeutics 2019, following MiNA Therapeutics’ successful liver cancer therapy news.
SMi Reports: 11th Annual Conference and Exhibition on Pre-Filled Syringes & Injectable Drug Devices will take place in just over a months’ time on the 16th-17th January 2019 in London.
SMi Reports: This year’s RNA Therapeutics Conference Chair Ekkehard Leberer, Senior Director at Sanofi-Aventis Deutschland GmbH, has released a letter of invitation detailing next year’s event.
Satisfied Users & 
Approved Press Releases
